These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3130270)

  • 21. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
    Sabol B; Boldry R; Farooqui T; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1987 May; 36(10):1679-85. PubMed ID: 3109428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Brain Res; 1994 Aug; 655(1-2):233-6. PubMed ID: 7812777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437.
    Timmerman W; Westerink BH; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1989 Mar; 162(1):143-50. PubMed ID: 2566492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.
    MacKenzie RG; Stachowiak MK; Zigmond MJ
    Eur J Pharmacol; 1989 Sep; 168(1):43-52. PubMed ID: 2511032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.
    Costall B; Kelly ME; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):29-35. PubMed ID: 6433208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex prejunctional actions of the D2 dopamine agonists N-0923 and N-0924 in the rat tail artery.
    Friedman DJ; Krause DN; Duckles SP
    J Pharmacol Exp Ther; 1992 Feb; 260(2):568-75. PubMed ID: 1346636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different actions of TL-99 and 3-PPP in producing contraversive turning in the 6-OHDA-lesioned rat.
    Martin GE; Jones JH; Bendesky RJ
    Eur J Pharmacol; 1983 Sep; 92(3-4):275-8. PubMed ID: 6138266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.
    Timmerman W; Tepper PG; Bohus BG; Horn AS
    Eur J Pharmacol; 1990 Jun; 181(3):253-60. PubMed ID: 1974516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0923), a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptors in the mouse vas deferens but not in the rat vas deferens.
    Martin PL; Kelly M; Cusack NJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1342-8. PubMed ID: 7903387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.